Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Scientific Industries, Inc. (OTCQB: SCND), a prominent developer of bioprocessing products and vision-based pill counters, is set to participate in the Lytham Partners Fall 2025 Investor Conference, scheduled for September 30, 2025. The conference will be held virtually, allowing the company to reach a broader audience of investors interested in its innovative offerings.

The company will host a webcast presentation at 1:15 p.m. ET, which can be accessed through the conference home page or directly via a unique webinar link. Following the live presentation, a replay of the webcast will be available, providing an opportunity for those who cannot attend the live event to catch up on the information shared.

In addition to the webcast, Scientific Industries’ management will engage in virtual one-on-one meetings with investors throughout the event. Interested parties can arrange a meeting by contacting Lytham Partners directly or registering for the event online. This initiative demonstrates the company’s commitment to transparency and investor engagement, providing a platform to discuss its products and business strategies.

Scientific Industries specializes in the design and manufacture of bioprocessing systems known as DOTS and vision-based pill counters marketed under the VIVID brand, as well as various weighing instruments. Their products cater primarily to laboratories, including those at universities, hospitals, pharmaceutical companies, and pharmacies, emphasizing the company's role in the healthcare and research industries.

Investors are reminded that forward-looking statements included in the press release involve uncertainties that could result in actual outcomes differing from expectations. As such, stakeholders are advised to consider the associated risks as outlined in the company’s SEC filings.

For further inquiries, contacts listed include CEO Helena R. Santos and Joe Dorame, available via provided phone numbers or emails.

As Scientific Industries, Inc. (OTCQB: SCND) prepares for its participation in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025, investors should closely monitor this event as a potential inflection point for the company. Specializing in bioprocessing systems and pill counting technologies, Scientific Industries operates in critical markets that are projected to see significant growth due to advancements in biotechnologies and increased demand for pharmaceutical precision.

The company’s products, such as the DOTS bioprocessing systems and VIVID pill counters, are geared toward laboratories in universities, hospitals, and pharmaceutical companies. This positions SCND well to capture emerging trends in automation and data accuracy in lab environments. Given the ongoing push for more efficient and reproducible lab processes, their digitally simplified bioprocessing solutions may resonate well with current market needs.

Investors should pay attention to the insights shared during the webcast scheduled for 1:15 p.m. ET, as this venue often helps clarify company strategies and provides a platform for management to communicate growth potential and operational updates. Furthermore, the opportunity for one-on-one meetings with management is a valuable chance to gauge management’s confidence in their strategic direction and financial performance.

While there is inherent risk in the biotech sector, as implied by the company's forward-looking statements, the growing reliance on technology in the healthcare and pharmaceutical industries could provide a favorable backdrop for SCND’s innovations. Investors should consider the potential upside associated with market expansion, but remain cognizant of the risks detailed in the company's SEC filings. As always, maintaining a diversified investment approach and staying well-informed will be crucial as you evaluate SCND's long-term prospects ahead of and following the conference.